CD36, a signaling receptor and fatty acid transporter that regulates immune cell metabolism and fate

Y Chen, J Zhang, W Cui, RL Silverstein - Journal of Experimental …, 2022 - rupress.org
CD36 is a type 2 cell surface scavenger receptor widely expressed in many immune and
non-immune cells. It functions as both a signaling receptor responding to DAMPs and …

CD36 in chronic kidney disease: novel insights and therapeutic opportunities

X Yang, DM Okamura, X Lu, Y Chen… - Nature Reviews …, 2017 - nature.com
CD36 (also known as scavenger receptor B2) is a multifunctional receptor that mediates the
binding and cellular uptake of long-chain fatty acids, oxidized lipids and phospholipids …

[HTML][HTML] The multifunctionality of CD36 in diabetes mellitus and its complications—update in pathogenesis, treatment and monitoring

K Puchałowicz, ME Rać - Cells, 2020 - mdpi.com
CD36 is a multiligand receptor contributing to glucose and lipid metabolism, immune
response, inflammation, thrombosis, and fibrosis. A wide range of tissue expression includes …

Circulating CD5L is associated with cardiovascular events and all-cause mortality in individuals with chronic kidney disease

E Castelblanco, MR Sarrias, À Betriu… - Aging (Albany …, 2021 - pmc.ncbi.nlm.nih.gov
This study assessed the association of CD5L and soluble CD36 (sCD36) with the risk of a
cardiovascular event (CVE), including CV death and all-cause mortality in CKD. We …

[HTML][HTML] Circulating soluble CD36 is similar in type 1 and type 2 diabetes mellitus versus non-diabetic subjects

E Castelblanco, L Sanjurjo, M Falguera… - Journal of clinical …, 2019 - mdpi.com
The aim of this study was to determine whether plasma concentrations of sCD36 (soluble
CD36) are associated with the presence of type 1 or type 2 diabetes. Plasma levels of …

[HTML][HTML] The circulating fatty acid transporter soluble CD36 is not associated with carotid atherosclerosis in subjects with type 1 and type 2 diabetes mellitus

E Castelblanco, L Sanjurjo… - Journal of clinical …, 2020 - mdpi.com
This study aimed to determine the association of fatty acid transporter plasma soluble cluster
of differentiation 36 (sCD36) with subclinical carotid atherosclerosis (SCA). A cross-sectional …

Correlation between Serum CD36 Level and Lipid Profile in Patients with Type 2 Diabetes Mellitus, Khartoum State, Sudan

EEM Ali, AM Dafalla, YA Mohammed… - Journal of Diabetes …, 2023 - scirp.org
Background: Diabetes mellitus (DM) is a chronic metabolic disorder characterized by
hyperglycemia. DM-related dyslipidemia are associated with complications resulting from …

[PDF][PDF] Trabajo Original Otros

JA Bricio-Barrios, M del Toro-Equihua… - Nutr …, 2019 - nutricionhospitalaria.org
1Centro Universitario de Investigaciones Biomédicas y 2Facultad de Medicina. Universidad
de Colima. Colima, México. 3Cátedras CONACyT. Centro Universitario de Investigaciones …

Lack of change in serum sCD36 concentration in children with non-alcoholic fatty liver disease–A preliminary study

A Bobrus-Chociej, N Wasilewska… - Advances in Medical …, 2021 - Elsevier
Purpose Non-alcoholic fatty liver disease (NAFLD) is increasingly being recognized in the
pediatric population, therefore, the search for non-invasive parameters to predict …